Financials
Financial year 2025
Worth noting
- A loss two years in a row.
- Little cash and receivables against the short-term debts.
Gross margin
€ 0
Profit
Caution€ -6.9 million
▼ 457% vs 2024
Debts
Low€ 1.8 million
▲ 279% vs 2024
Health Economics Privak II from Nazareth-De Pinte, company number BE0685563039, closed financial year 2025 with a result of € -6.9 million after tax. For that financial year Health Economics Privak II recorded a gross margin of € 0 and equity of € 34.9 million. Compared with financial year 2024, the result moved from € -1.2 million to € -6.9 million. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.
What happened at Health Economics Privak II?
What happened at Health Economics Privak II in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 6.9 million. Source: NBB ↗
- Start of the company according to the CBE. KBO
In short
From € 3.5 million profit in 2021 to € 6.9 million loss in 2025.
Best year ever: 2021, with € 3.5 million profit.
Paid out € 4.2 million in dividends to the owners in total.
Pays suppliers within 22 days on average.
A new publication or filing at Health Economics Privak II? We notify you, reason included.
Follow Health Economics Privak IINeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind Health Economics Privak II are Anne Frida Magdalene Portwich, Fouad Oscar Azzam and Rudy Dekeyser. The shares are held by Participatiemaatschappij Vlaanderen NV (14.4%) and BNP Paribas Fortis Private Equity Belgium NV (14.4%). It owns 100% of Health Economics Belgium II itself.
Directors
According to the 2025 annual accounts
Anne Frida Magdalene Portwich
Director
Fouad Oscar Azzam
Director
Rudy Dekeyser
Managing director
Also active at: reMYND, ANTIKANKERFONDS-FONDS ANTICANCER-ANTICANCER FUND, R.A.D. LIFE SCIENCES +6 more
Shareholders
Participations
Establishments
Establishment units
Physical locations of this company
Klein Nazareth 12
9840 Nazareth-De Pinte
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 8 companies are registered at this address.
R.A.D. LIFE SCIENCES same network
€ 7,189 gross margin · 2025
SysteemUnoDue
LSP 6 Privak same network
LSP 7 Privak same network
EQT Health Economics 3 Privak same network
+3 more
Details
- Company number
- 0685.563.039
- VAT number
- BE 0685.563.039
- Registered office
- Klein Nazareth 12, 9840 Nazareth-De Pinte
- Names & denominations
- Health Economics Privak II
- Enterprise type
- Rechtspersoon
- Legal form
- Limited partnership
- Legal situation
- Normale toestand
- Start date
- 1 December 2017
- Peppol
- Not registered